Skip to content
WeighLab
Menu
Ranked #105 · Grade C

Layla review

Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

Visit Layla Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$237/mo (all doses, compounded)
Tirzepatide
$199/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$2,844

Tirzepatide · modeled / year

$2,388

The Index scorecard

Layla scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month77/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options90/100
Clinical Oversight76/100
Contract Flexibility55/100

Where the value is

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

The tradeoffs

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

The bottom line

Best for: People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path. Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

Ranked #105 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Layla.

The 18 programs nearest this one

Pricing, states and verification reflect Layla's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Layla's site. Not medical advice; see our disclosure.

← Back to the value leaderboard